Micro-fluidic chip for efficient drug screening
A microfluidic chip and drug technology, applied to laboratory containers, biochemical equipment and methods, tissue cell/virus culture devices, etc., can solve the problem of increasing the length of the flow channel, reducing the concentration gradient formation efficiency, and drug loss Increase and other problems, to achieve the effect of reducing the number of layers of the flow channel structure, improving the efficiency of drug screening, and reducing the loss of drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0101] In this embodiment, the width range of the channels in the first distribution channel group 302 is 50-1500 μm, and the depth range is 2-20 μm; the width range of the channels in the second distribution channel 3040 is 30-200 μm, and the depth range is 2-20 μm. 25 μm.
[0102] In one embodiment, the numbers are sequentially numbered from top to bottom, and the volumes of the 1st to 3rd first distribution channels 3020 are U 0 , 3U 0 、9U 0 , the volumes of the three second distribution channels 3040 connected after each first distribution channel 3020 are V from top to bottom 0 , 1.5V 0 , 2V 0 , that is, the volume ratio of the three second distribution channels 3040 in each second distribution channel group 304 is Among them, U 0 and V 0 Both can represent a unit volume; and in this embodiment, the channel lengths in the first distribution channel group 302 and the second distribution channel group 304 are equal, so the above volume ratio is also equal to the are...
Embodiment 2
[0116] refer to Figure 8-10 , in this embodiment, the first distribution cavity 301 includes a first V-shaped cavity section 3010 and a first rectangular cavity section 3011 that communicate with each other, the first V-shaped cavity section 3010 communicates with the drug inlet, and the first rectangular cavity section 3011 communicates with the upstream of the first distribution channel 3020;
[0117] The second distribution cavity 303 includes a second V-shaped cavity segment 3030 and a second rectangular cavity segment 3031 that communicate with each other, the second V-shaped cavity segment 3030 communicates with the downstream of the first distribution channel 3020, and the second rectangular cavity segment 3031 communicates with the first distribution channel 3020. The upstream of the two distribution channels 3040 is connected.
[0118] Through the arrangement of the V-shaped chamber section, the solution in the distribution chamber can be more evenly distributed thr...
Embodiment 3
[0129] refer to image 3 , Figure 11-14 , the end of the third mixing channel 45 has a first flaring section 47, and the first flaring section 47 communicates with the side of the cell culture chamber 50; by setting the first flaring section 47, it can facilitate the rapid entry of liquid into the cell culture chamber 50 .
[0130] A one-way valve 48 is disposed in the third mixing channel 45 , and the one-way valve 48 is located between the outlet end of the fourth mixing channel 46 and the first flaring section 47 . The one-way valve 48 acts as a non-return valve. By setting the one-way valve 48, it is ensured that the candidate drug solution after the concentration is configured can smoothly enter the cell culture chamber 50, and the culture fluid or cells in the cell culture chamber 50 will not flow backward toward the chip body. 1 upstream flow.
[0131] refer to Figure 11-12 , in one embodiment, the one-way valve 48 includes a sealing piece 485 and a limiting block...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


